Literature DB >> 8039600

The role of liver glucosensors in the integrated sympathetic response induced by deep hypoglycemia in dogs.

M Hamilton-Wessler1, R N Bergman, J B Halter, R M Watanabe, C M Donovan.   

Abstract

The significance of the portohepatic glucosensors for counterregulation in deep hypoglycemia (i.e., glycemia < 2.8 mM) was studied in chronically cannulated male mongrel dogs in the conscious state. A total of 16 experiments were carried out on 6 dogs using the liver clamp technique under hyperinsulinemic conditions (insulin infusion, 39 pmol.min-1.kg-1, 0-150 min). The level of glycemia presented to the liver was made to differ from the systemic arterial glucose level via portal glucose infusion. Tracer-determined rates of glucose clearance and hepatic glucose output (HGO) were assessed using D-[3-3H]glucose (0.26 microCi.min-1). Three protocols were used. In protocol I, liver clamp, systemic hypoglycemia at 2.60 +/- 0.09 mM, and liver glycemia at 3.86 +/- 0.05 mM were achieved with portal glucose infusion (28.2 +/- 3.0 mumol.min-1.kg-1). For protocol II, glucose was infused peripherally (18.2 +/- 4.3 mumol.min-1.kg-1), while systemic and liver glycemia were sustained at deep hypoglycemia, 2.50 +/- 0.08 mM. In protocol III, via peripheral glucose infusion (62.9 +/- 5.8 mumol.min-1.kg-1), systemic and liver glycemia were maintained at a level matched to the liver glycemia during protocol I (3.98 +/- 0.05 mM, P > 0.10). When compared with protocols I and III, the catecholamine response above basal was significantly greater during protocol II with liver and systemic deep hypoglycemia (7.30 +/- 1.51 and 2.89 +/- 0.5 nM for epinephrine and norepinephrine, respectively, P < 0.005). These values reflect net increases in the catecholamine responses of 100% and 85% for epinephrine and norepinephrine when compared with protocol I.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039600     DOI: 10.2337/diab.43.8.1052

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

1.  GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization.

Authors:  Rémy Burcelin; Valerie Crivelli; Christophe Perrin; Anabela Da Costa; James Mu; Barbara B Kahn; Morris J Birnbaum; C Ronald Kahn; Peter Vollenweider; Bernard Thorens
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

2.  Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors.

Authors:  Nell Marty; Michel Dallaporta; Marc Foretz; Martine Emery; David Tarussio; Isabelle Bady; Christophe Binnert; Friedrich Beermann; Bernard Thorens
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones.

Authors:  V Ionut; K Hucking; I F Liberty; R N Bergman
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

Review 4.  Peripheral and central glucose sensing in hypoglycemic detection.

Authors:  Casey M Donovan; Alan G Watts
Journal:  Physiology (Bethesda)       Date:  2014-09

Review 5.  GLUT2, glucose sensing and glucose homeostasis.

Authors:  Bernard Thorens
Journal:  Diabetologia       Date:  2014-11-25       Impact factor: 10.122

6.  Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats.

Authors:  M A Borg; R S Sherwin; W P Borg; W V Tamborlane; G I Shulman
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

Review 7.  A reappraisal of the blood glucose homeostat which comprehensively explains the type 2 diabetes mellitus-syndrome X complex.

Authors:  Johan H Koeslag; Peter T Saunders; Elmarie Terblanche
Journal:  J Physiol       Date:  2003-04-25       Impact factor: 5.182

8.  Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal.

Authors:  Dan Zheng; Viorica Ionut; Vahe Mooradian; Darko Stefanovski; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

9.  Essentiality of portal vein receptors in hypoglycemic counterregulation: direct proof via denervation in male canines.

Authors:  Viorica Ionut; Ana Valeria B Castro; Orison O Woolcott; Darko Stefanovski; Malini S Iyer; Josiane L Broussard; Hasmik Mkrtchyan; Miguel Burch; Ram Elazary; Erlinda Kirkman; Richard N Bergman
Journal:  Endocrinology       Date:  2014-01-15       Impact factor: 4.736

10.  2. Hypoglycemia Detection.

Authors:  Vanessa H Routh; Casey M Donovan; Sue Ritter
Journal:  Transl Endocrinol Metab       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.